Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

The genetics of complex disease produce alterations in the molecular interactions of cellular
pathways whose collective effect may become clear through the organized structure of …

Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to broadly regulate the
cellular stress response. In contrast, it is unclear if the PACAP–PAC1 receptor pathway has …

Objective: While the apolipoprotein E (APOE) ε/allele is a well-established risk factor for late-onset
Alzheimer’s disease (AD), initial genome scans using microsatellite markers in late-…

It is widely assumed that genetic differences in gene expression underpin much of the difference
among individuals and many of the quantitative traits of interest to geneticists. Despite …

The apolipoprotein E (APOE) ɛ4 allele is the best established genetic risk factor for late-onset
Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-…

Alzheimer's disease (AD) and related dementias are a major public health challenge and
present a therapeutic imperative for which we need additional insight into molecular …

We recently surveyed the relationship between the human brain transcriptome and genome
in a series of neuropathologically normal postmortem samples. We have now analyzed …

Each additional copy of the apolipoprotein E4 (APOE4) allele is associated with a higher risk
of Alzheimer’s dementia, while the APOE2 allele is associated with a lower risk of Alzheimer…